WHG
GILD icon

Westwood Holdings Group’s Gilead Sciences GILD Stock Holding History

Westwood Holdings Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.3M Sell
303,467
-25,315
-8% -$3.55M 0.31% 110
2025
Q4 		$40.4M Sell
328,782
-3,473
-1% -$422K 0.33% 111
2025
Q3 		$36.9M Sell
332,255
-1,797
-0.5% -$204K 0.26% 128
2025
Q2 		$37M Buy
334,052
+11,145
+3% +$1.19M 0.27% 125
2025
Q1 		$36.2M Buy
322,907
+86,583
+37% +$8.93M 0.27% 125
2024
Q4 		$21.8M Sell
236,324
-28,926
-11% -$2.6M 0.17% 166
2024
Q3 		$22.2M Buy
265,250
+57,003
+27% +$4.35M 0.09% 206
2024
Q2 		$14.3M Sell
208,247
-248,465
-54% -$16.6M 0.07% 220
2024
Q1 		$33.5M Sell
456,712
-834,552
-65% -$64.2M 0.26% 131
2023
Q4 		$105M Sell
1,291,264
-38,338
-3% -$2.98M 0.88% 20
2023
Q3 		$99.6M Sell
1,329,602
-37,108
-3% -$2.85M 0.93% 22
2023
Q2 		$105M Sell
1,366,710
-358,546
-21% -$28.6M 0.94% 16
2023
Q1 		$143M Buy
1,725,256
+244,025
+16% +$20.2M 1.29% 9
2022
Q4 		$127M Sell
1,481,231
-110,659
-7% -$8.76M 1.12% 14
2022
Q3 		$98.2M Sell
1,591,890
-37,133
-2% -$2.34M 1.16% 13
2022
Q2 		$101M Sell
1,629,023
-106,617
-6% -$6.6M 1.1% 11
2022
Q1 		$103M Buy
1,735,640
+280,942
+19% +$18M 0.95% 19
2021
Q4 		$106M Buy
1,454,698
+114,470
+9% +$7.88M 0.95% 18
2021
Q3 		$93.6M Buy
1,340,228
+971,413
+263% +$68.2M 1.02% 16
2021
Q2 		$25.4M Buy
368,815
+66,428
+22% +$4.44M 0.26% 134
2021
Q1 		$19.5M Buy
302,387
+24,152
+9% +$1.56M 0.2% 159
2020
Q4 		$16.2M Sell
278,235
-56,505
-17% -$3.41M 0.19% 157
2020
Q3 		$21.2M Sell
334,740
-167,899
-33% -$11.6M 0.27% 125
2020
Q2 		$38.7M Buy
502,639
+24,493
+5% +$1.88M 0.51% 57
2020
Q1 		$35.7M Buy
+478,146
New +$33M 0.54% 51
2019
Q3 		– Sell
-6,610
Closed -$447K – 490
2019
Q2 		$447K Buy
+6,610
New +$435K ﹤0.01% 399
2017
Q3 		– Sell
-399
Closed -$28K – 463
2017
Q2 		$28K Buy
+399
New +$26.6K ﹤0.01% 474
2017
Q1 		– Sell
-4,910
Closed -$352K – 414
2016
Q4 		$352K Sell
4,910
-24,125
-83% -$1.79M ﹤0.01% 402
2016
Q3 		$2.3M Sell
29,035
-12,285
-30% -$998K 0.02% 292
2016
Q2 		$3.45M Sell
41,320
-75
-0.2% -$6.66K 0.03% 259
2016
Q1 		$3.8M Buy
41,395
+70
+0.2% +$6.31K 0.03% 245
2015
Q4 		$4.18M Sell
41,325
-33,235
-45% -$3.46M 0.04% 243
2015
Q3 		$7.32M Buy
74,560
+24,600
+49% +$2.73M 0.06% 198
2015
Q2 		$5.85M Sell
49,960
-2,610
-5% -$285K 0.04% 224
2015
Q1 		$5.16M Sell
52,570
-7,280
-12% -$739K 0.04% 218
2014
Q4 		$5.64M Sell
59,850
-28,900
-33% -$2.99M 0.04% 219
2014
Q3 		$9.45M Buy
88,750
+24,950
+39% +$2.44M 0.07% 179
2014
Q2 		$5.29M Buy
+63,800
New +$4.97M 0.04% 216

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Westwood Holdings Group's GILD Position: Q1 2026 in Review

Westwood Holdings Group reduced its Gilead Sciences (GILD) stake by 7.7% in Q1 2026, selling an estimated $3.55M and leaving 303,467 shares worth $42.3M. The position accounts for 0.31% of the portfolio, ranked #110.

Westwood Holdings Group first reported a position in GILD in Q2 2014 and has held it in 38 quarters since. The position peaked at $143M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Westwood Holdings Group held 303,467 shares of Gilead Sciences worth $42.3M as of Q1 2026.
  • Westwood Holdings Group sold 25,315 Gilead Sciences shares in Q1 2026, an estimated $3.55M.
  • Gilead Sciences made up 0.31% of Westwood Holdings Group's portfolio in Q1 2026, its #110 holding.
  • Westwood Holdings Group first reported a position in Gilead Sciences in Q2 2014 and has held it in 38 quarters since.
  • Westwood Holdings Group's Gilead Sciences position peaked at $143M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Westwood Holdings Group's 13F filing for Q1 2026, filed 15 May 2026.